Abiopharma

🔍 Maday David (Executive)

Company: Aurora Innovation, Inc. (AUR)

Report Date: 2026-08-20

Detailed Transactions and Holdings:

• Sold 54,412 shares of Class A Common Stock at $6.2 per share (Direct)
  Date: 2026-08-20 | Code: F | equity_swap_involved: 0 | shares_owned_after: 1,900,092.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-08-20 | Code: H | nature_of_ownership: Held by The Maday Irrevocable Gift Trust F/B/O Blake J. Maday | shares_owned_after: 79,874.00 | Footnotes: F2
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-08-20 | Code: H | nature_of_ownership: Held by The Maday Irrevocable Gift Trust F/B/O Samantha L. Maday | shares_owned_after: 79,873.00 | Footnotes: F2

Footnotes:

• F1: Represents (i) 13,626 shares of Class A common stock withheld by the Issuer to cover the reporting person's tax withholding obligation upon the quarterly vesting of Restricted Stock Units granted on June 14, 2023; (ii) 7,786 shares of Class A common stock withheld by the Issuer to cover the reporting person's tax withholding obligation upon the quarterly vesting of Restricted Stock Units granted on March 8, 2024; (iii) 15,141 shares of Class A common stock withheld by the Issuer to cover the reporting person's tax withholding obligation upon the quarterly vesting of Restricted Stock Units granted on March 24, 2025; and (iv) 17,859 shares of Class A common stock withheld by the Issuer to cover the reporting person's tax withholding obligation upon the quarterly vesting of Restricted Stock Units granted on March 23, 2026.
• F2: The reporting person is a trustee of the trust. The reporting person, in such capacity, may be deemed a beneficial owner of the securities held by the trust.